🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524330-25-00
Authorised Phase I

Phase 1, Randomized, Open-label, Single center study to evaluate Pharmacokinetic and Bioequivalence of Levonorgestrel Vaginal Delivery System in Healthy Female Volunteers after different days of use

2025-524330-25-00 · tracked via the Priya Life Science EU tracker
Sponsor
Chemo Research S.L.
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
27/03/2026
Enrollment target
60
Sites
Spain

Condition studied

No medical condition

Eligibility

Age group
18-64 years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524330-25-00 on CTIS ↗ ← All trials in the EU